DE3007402C2 - Verfahren zum Reduzieren von Pertechnetat - Google Patents
Verfahren zum Reduzieren von PertechnetatInfo
- Publication number
- DE3007402C2 DE3007402C2 DE3007402A DE3007402A DE3007402C2 DE 3007402 C2 DE3007402 C2 DE 3007402C2 DE 3007402 A DE3007402 A DE 3007402A DE 3007402 A DE3007402 A DE 3007402A DE 3007402 C2 DE3007402 C2 DE 3007402C2
- Authority
- DE
- Germany
- Prior art keywords
- tin
- pertechnetate
- solution
- metal
- copper
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
- A61K51/0478—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from non-cyclic ligands, e.g. EDTA, MAG3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/025—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus inorganic Tc complexes or compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0489—Phosphates or phosphonates, e.g. bone-seeking phosphonates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01G—COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
- C01G37/00—Compounds of chromium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2123/00—Preparations for testing in vivo
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Optics & Photonics (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Physics & Mathematics (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Inorganic Chemistry (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dispersion Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Inorganic Compounds Of Heavy Metals (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB7906883 | 1979-02-27 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE3007402A1 DE3007402A1 (de) | 1980-09-04 |
| DE3007402C2 true DE3007402C2 (de) | 1986-10-09 |
Family
ID=10503463
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE3007402A Expired DE3007402C2 (de) | 1979-02-27 | 1980-02-27 | Verfahren zum Reduzieren von Pertechnetat |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US4314986A (https=) |
| JP (1) | JPS6016375B2 (https=) |
| DE (1) | DE3007402C2 (https=) |
| FR (1) | FR2450234A1 (https=) |
| GB (1) | GB2046000B (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4401646A (en) * | 1981-05-08 | 1983-08-30 | University Patents Inc. | Method and apparatus for purifying materials radiolabeled with technetium-99m |
| US4707353A (en) * | 1982-12-08 | 1987-11-17 | Mallinckrodt, Inc. | Radiographic imaging agents |
| US4510125A (en) * | 1982-12-08 | 1985-04-09 | Mallinckrodt, Inc. | Process for making lyophilized radiographic imaging kit |
| EP0163701A1 (en) * | 1983-12-06 | 1985-12-11 | The Royal Melbourne Hospital | PREPARATION OF RADIOPHARMACEUTICALS BASED ON TECHNETIUM-99m/ |
| JPS6293320A (ja) * | 1985-10-18 | 1987-04-28 | Japan Atom Energy Res Inst | テクネチウムの回収法 |
| CA2158249A1 (en) * | 1993-03-31 | 1994-10-13 | James W. Brodack | Radiopharmaceutical formulations having non-stannous reductants |
| WO1995030443A1 (en) * | 1994-05-05 | 1995-11-16 | Albany Medical College | Method for production of radiolabeled drug product |
| US6359119B1 (en) * | 2000-05-24 | 2002-03-19 | Mallinckrodt Inc. | Formulation of Tc and Re carbonyl complexes using stannous ion as the reductant for pertechnetate and perrhenate |
| CN114948890B (zh) * | 2021-02-25 | 2023-07-04 | 成都云克药业有限责任公司 | 一种锝[99Tc]亚甲基二膦酸盐包衣片及其制备方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3902849A (en) * | 1971-08-19 | 1975-09-02 | Medi Physics Inc | Radioisotope and radiopharmaceutical generators |
| US3873680A (en) * | 1972-08-30 | 1975-03-25 | Minnesota Mining & Mfg | Mercaptan and thioketal complexes of technetium 99M for diagnostic scanning |
| US3976762A (en) * | 1974-07-05 | 1976-08-24 | Minnesota Mining And Manufacturing Company | Multi-organ technetium complexes production and use thereof |
-
1980
- 1980-02-19 GB GB8005490A patent/GB2046000B/en not_active Expired
- 1980-02-25 JP JP55022631A patent/JPS6016375B2/ja not_active Expired
- 1980-02-25 US US06/124,237 patent/US4314986A/en not_active Expired - Lifetime
- 1980-02-27 DE DE3007402A patent/DE3007402C2/de not_active Expired
- 1980-02-27 FR FR8004318A patent/FR2450234A1/fr active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| FR2450234B1 (https=) | 1983-11-18 |
| JPS6016375B2 (ja) | 1985-04-25 |
| US4314986A (en) | 1982-02-09 |
| GB2046000B (en) | 1982-11-24 |
| DE3007402A1 (de) | 1980-09-04 |
| JPS55116630A (en) | 1980-09-08 |
| FR2450234A1 (fr) | 1980-09-26 |
| GB2046000A (en) | 1980-11-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE68924795T2 (de) | Verfahren zur Radiomarkierung von Proteinen. | |
| DE69030025T2 (de) | Verfahren zur Markierung von Proteinen mit Technetium/Rhenium | |
| DE2825216C2 (https=) | ||
| DE3781031T2 (de) | Markierung von traegermolekuelen mit metallionen. | |
| DE3007402C2 (de) | Verfahren zum Reduzieren von Pertechnetat | |
| CH649924A5 (de) | Reduktionsmaterial zur reduktion von technetium unter bildung eines technetiummarkierten liganden. | |
| DE2538388A1 (de) | Verfahren zur herstellung eines stabilen, nicht-radioaktiven traegermaterials und seine verwendung zur herstellung von tc-99m-markierten diagnosemitteln | |
| EP0271806A2 (de) | Verfahren zur Herstellung einer mit Technetium-99m-markierten organspezifischen Substanz | |
| DE2322758A1 (de) | Verfahren zur herstellung von injizierbaren praeparaten des tc99m und/oder in113m und vorrichtung zur durchfuehrung des verfahrens | |
| DE2907880C2 (https=) | ||
| DE3131572C2 (https=) | ||
| DE1814028B2 (de) | Verfahren zur bestimmung des gehalts an freiem und gebundenem hydroxyprolin von koerperfluessigkeiten | |
| DE69033953T2 (de) | Kolloidale radiomarkierte zusammensetzungen, deren anwendung und verfahren zu deren herstellung | |
| DE2534985C2 (https=) | ||
| DE69327748T2 (de) | Verfahren zur Herstellung von Yttrium-90 mit einem Yttrium-90-Generator | |
| DE602005006157T2 (de) | STABILISIERTE 99mTC ZUSAMMENSETZUNG | |
| DE60027436T2 (de) | Zusammensetzung von radiopharmazeutischen Metallkomplexen in Silika-beschichteten Behältnissen | |
| DE2617895C3 (de) | Dispersion zur Herstellung eines injizierbaren radiopharmazeutischen Scanning-Mittels | |
| JPS61501321A (ja) | たんぱく様物質標識用テクネチウム99m組成物およびその使用方法 | |
| DE2820895A1 (de) | Verfahren zur bestimmung einer komponente in einer biologischen fluessigkeit | |
| DE2115066A1 (de) | Verpackungseinheit fur radioaktive Kennzeichnungsmittel | |
| EP1713516B1 (de) | Verfahren und kit zur herstellung von rhenium-188 markierten partikeln | |
| US4042676A (en) | Technetium-99m labeled radiodiagnostic agents for liver and bone marrow scanning and method of preparation | |
| DE69922052T2 (de) | Immobilisierte marker-verbindungen und verfahren | |
| EP0498333B1 (de) | Verfahren zur Herstellung einer mit Technetium-99m markierten organspezifischen Substanz |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8110 | Request for examination paragraph 44 | ||
| 8128 | New person/name/address of the agent |
Representative=s name: LEDERER, F., DIPL.-CHEM. DR., PAT.-ANW., 8000 MUEN |
|
| D2 | Grant after examination | ||
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |